There is little information regarding the comparative hemodynamic effects of adding milrinone or levosimendan to dopamine infusion in hypoxia-reoxygenated (H-R) newborns. Twenty-eight piglets (1–4 d, ...

Please provide your email address to receive an email when new articles are posted on . Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and ...

Please provide your email address to receive an email when new articles are posted on . In the CAPITAL Do-Re-Mi trial, there was no difference in outcomes in patients treated with the widely used ...

Background: Low systemic blood flow as measured by superior vena cava (SVC) flow is common in very preterm infants. It is strongly associated with IVH and disability and may be caused by poor cardiac ...

Feb. 24, 2003 — Milrinone significantly reduced the development of low output cardiac syndrome (LCOS) in children undergoing corrective surgery for congenital heart disease, according to the results ...

Bedford Laboratories announced the addition of milrinone lactate in 5% dextrose injection (0.2mg/mL) in single-dose PVC flexible containers to its existing milrinone injection line. This product is AP ...

A head-to-head comparison of inotropes in the setting of cardiogenic shock revealed no clear victor, with milrinone and dobutamine providing similar outcomes in the randomized DOREMI trial. A ...

A drug commonly used for short-term treatment of worsening heart failure in hospitalized patients may cause dangerously low blood pressure and abnormal heart rhythms, researchers found. The findings ...

Adult: IV- Loading dose: 50 mcg/kg then continuous maintenance infusion of 0.375-0.75 mcg/kg/min. Adjust according to response. Max:1.13 mcg/kg/day. Myocarditis is an inflammation of the heart muscle.

Targeting orphan, late-stage heart failure indication with high unmet medical needs Liège, Belgium – 8 October 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company ...